Autopsy report · NCT00648414

Study of the Effect of Clinical Procedures on Drug Delivery of Mylan Fentanyl Transdermal System 25 µg/hr and Duragesic® 25 µg/hr

“due to multiple subjects reporting pain and burning at the phlebotomy sites after 38hr”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 5 months after it had already started.
• 12 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Mylan Pharmaceuticals Inc

Sponsor type

Industry

Conditions

Healthy

Interventions

Mylan Fentanyl Transdermal System 25 mcg/h + Clinical Procedure 1; Mylan Fentanyl Transdermal System 25 mcg/h + Clinical Procedure 2; Mylan Fentanyl Transdermal System 25 mcg/h + Clinical Procedure 3; Duragesic 25 mcg/h + Clinical Procedure 1; Duragesic 25 mcg/h + Clinical Procedure 2; Duragesic 25 mcg/h + Clinical Procedure 3

Participants

12

Sites

1

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.